EAHFE – TROPICA2 study. Prognostic value of troponin in patients with acute heart failure treated in Spanish hospital emergency departments

References

• Arenja, N., et al., 2012. Sensitive cardiac troponin in the diagnosis and risk stratification of acute heart failure. Journal of internal medicine, 271 (6), 598–607.
   PubMed Web of Science ®Google Scholar
• Avellino, A., Collins, S.P., and Fermann, G.J., 2011. Risk stratification and short-term prognosis in acute heart failure syndromes: a review of novel biomarkers. Biomarkers, 16 (5), 379–392.
   PubMed Web of Science ®Google Scholar
• Bueno, H., 2015. Acute heart failure in Spain: certainties and uncertainties. Emergencias, 27 (1), 7–8.
   Web of Science ®Google Scholar
• Cediel, G., et al., 2016. Elevated troponin I level in patients discharged home directly from the emergency department: prognostic value for 1-year mortality. Emergencias, 28, 298–304.
   Web of Science ®Google Scholar
• Collins, S.P., et al., 2015. Identification of emergency department patients with acute heart failure at low risk for 30-day adverse events: the STRATIFY decision tool. JACC heart failure, 3 (10), 737–747.
   PubMed Web of Science ®Google Scholar
• De Antonio, M., et al., 2013. Head-to-head comparison of high-sensitivity troponin T and sensitive-contemporary troponin I regarding heart failure risk stratification. Clinical chimca acta, 426, 18–24.
   PubMed Web of Science ®Google Scholar
• Diez, M., et al. 2016. High-sensitivity troponin is associated with high risk clinical profile and outcome in acute heart failure. Cardiology journal, 23 (1), 78–83.
   PubMed Web of Science ®Google Scholar
• Felker, G.M., et al., 2012. Troponin I in acute decompensated heart failure: insights from the ASCEND-HF study. European journal of heart failure, 14 (11), 1257–1264.
   PubMed Web of Science ®Google Scholar
• Felker, G.M., et al., 2015. Serial high sensitivity cardiac troponin T measurement in acute heart failure: insights from the RELAX-AHF study. European journal of heart failure, 17 (12), 1262–1270.
   PubMed Web of Science ®Google Scholar
• Grodin, J.L., et al., 2015. Prognostic comparison of different sensitivity cardiac troponin assays in stable heart failure. American journal of medicine, 128 (3), 76–82.
   Web of Science ®Google Scholar
• Guisado, M.E., et al., 2014. Troponin T in acute heart failure: clinical implications and prognosis in the Spanish national registry on heart failure. European journal of internal medicine, 25 (8), 739–744.
   PubMed Web of Science ®Google Scholar
• Ilva, T., et al., 2008. Clinical significance of cardiac troponins I and T in acute heart failure. European journal of heart failure, 10 (8), 772–779.
   PubMed Web of Science ®Google Scholar
• Jacob, J., et al., 2011. Prognostic value of emergency department testing for N-terminal fragment of brain natriuretic peptide in patients with acute heart failure: the PICASU-1 study. Emergencias, 23 (3), 183–192.
   Web of Science ®Google Scholar
• Jacob, J., et al., 2013. Prognostic value of troponin in patients with acute heart failure attended in Spanish emergency departments: TROPICA study (TROPonin in acute heart failure). Medicina clinica, 140 (4), 145–151.
   PubMed Web of Science ®Google Scholar
• Jacob, J., et al., 2016. Predicting short-term mortality in patients with acute exacerbation of chronic heart failure: The EAHFE-3D scale. Medicina intensiva, 40 (6), 348–355.
   PubMed Web of Science ®Google Scholar
• Jungbauer, C.G., et al., 2011. High-sensitive troponin T in chronic heart failure correlates with severity of symptoms, left ventricular dysfunction and prognosis independently from N-terminal pro-b-type natriuretic peptide. Clinical chemistry and laboratory medicine, 49 (11), 1899–1906.
   PubMed Web of Science ®Google Scholar
• Lee, D.S., et al., 2012. Prediction of heart failure mortality in emergent care: a cohort study. Annals of internal medicine, 156 (11), 767–775.
   PubMed Web of Science ®Google Scholar
• Llorens, P., et al., 2015a. EAHFE registry (epidemiology of acute heart failure in Spanish emergency departments): clinical characteristics, therapeutic approach and outcomes of patients diagnosed of acute heart failure at Spanish emergency departments. Emergencias, 27, 11–22.
   PubMed Web of Science ®Google Scholar
• Llorens, P., et al., 2015b. Consensus on improving the care integrated of patients with acute heart failure. Emergencias, 27 (4), 245–266.
   Web of Science ®Google Scholar
• McKee, P.A., et al., 1971. The natural history of congestive heart failure: the Framingham study. The New England journal of medicine, 285 (26), 1441–1446.
   PubMed Web of Science ®Google Scholar
• McMurray, J.J., et al., 2012. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European society of cardiology. Developed in collaboration with the heart failure association (HFA) of the ESC. European journal of heart failure, 14 (8), 803–869.
   PubMed Web of Science ®Google Scholar
• Metra, M., et al., 2013. Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the relaxin in acute heart failure (RELAX-AHF) development program: correlation with outcomes. Journal of the American college of cardiology, 61 (2), 196–206.
   PubMed Web of Science ®Google Scholar
• Mills, N.L., et al., 2011. Implementation of a sensitive troponin I assay and risk of recurrent myocardial infarction and death in patients with suspected acute coronary syndrome. The journal of American medical association, 305 (12), 1210–1216.
   PubMed Web of Science ®Google Scholar
• Miró, Ò., et al., 2001. Prognostic implications on the possibility to urgent testing for N-terminal fragment of brain natriuretic peptide in emergency department in patients with acute heart failure: the PICASU-2 study. Emergencias, 23, 437–446.
   Google Scholar
• Miró, Ò., et al., 2015. Patients’ perception of quality of emergency department care for acute heart failure: the CALPERICA study. Emergencias, 27 (3), 161–168.
   Web of Science ®Google Scholar
• Pang, P.S., et al., 2016. Use of high-sensitivity troponin T to identify patients with acute heart failure at lower risk for adverse outcomes: an exploratory analysis from the RELAX-AHF trial. JACC: heart failure, 4 (7), 591–599.
   PubMed Web of Science ®Google Scholar
• Pascual-Figal, D.A., et al., 2012. Highly sensitive troponin T for risk stratification of acutely destabilized heart failure. American heart journal, 163 (6), 1002–1010.
   PubMed Web of Science ®Google Scholar
• Peacock, W.F., et al., 2008. Cardiac troponin and outcome in acute heart failure. The New England journal of medicine, 358 (2), 2117–2126.
   PubMed Web of Science ®Google Scholar
• Perna, E.R., et al., 2005. Minor myocardial damage detected by troponin T is a powerful predictor of long-term prognosis in patients with acute decompensated heart failure. International journal of cardiology, 99 (2), 253–261.
   PubMed Web of Science ®Google Scholar
• Ponikowski, P., et al., 2016. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European society of cardiology (ESC). European heart journal, 37 (27), 2129–2200.
   PubMed Web of Science ®Google Scholar
• Roberts, E., et al., 2015. The diagnostic accuracy of the natriuretic peptides in heart failure: systematic review and diagnostic meta-analysis in the acute care setting. BMJ clinical research, 350, h910. doi: 10.1136/bmj.h910.
   Google Scholar
• Rubini, M. and, Mueller, C., 2016. Discharged from the emergency department with elevated troponin levels? Emergencias, 28, 291–292.
   Web of Science ®Google Scholar
• Stiell, I.G., et al., 2013. A risk scoring system to identify emergency department patients with heart failure at high risk for serious adverse events. Academic emergency medicine, 20 (1), 17–26.
   PubMed Web of Science ®Google Scholar
• van Wijk, S., et al., 2012. Troponin T measurements by high-sensitivity vs conventional assays for risk stratification in acute dyspnea. Clinical chemistry, 58 (1), 284–292.
   PubMed Web of Science ®Google Scholar